Iyer, Harini
Benoist, Christophe https://orcid.org/0000-0003-1172-6555
Bilbo, Staci D.
Boulanger, Lisa M.
Burton, Michael D. https://orcid.org/0000-0002-0628-824X
Daniels, Brian P.
Deczkowska, Aleksandra
Flajnik, Martin F.
Gareau, Mélanie G.
Grace, Peter M.
Irazoqui, Javier E. https://orcid.org/0000-0001-6553-1329
Rosi, Susanna
Salinas, Irene
Schaefer, Anne https://orcid.org/0000-0002-1051-3710
Sokol, Caroline L. https://orcid.org/0000-0003-0473-7555
Williams, Dionna W.
Klein, Robyn S. https://orcid.org/0000-0003-0281-1352
Funding for this research was provided by:
Canada Excellence Research Chairs, Government of Canada (R7534A01)
U.S. Department of Health & Human Services | National Institutes of Health (1R01AI182126, R01AT009365, R21MH108154, R35GM149284, R01GM101056, R21AI169842, R01MH118329, R01NS106721, RF1AG068558, R01AG072489, ERC-951515)
New Jersey Alliance for Clinical and Translational Research Science New Jersey Commission on Brain Injury Research
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R35GM147094)
University of Texas System STARS Program Rita Allen Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS120895, R21NS130282)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1R01AI140326, 1R01AI170844)
Altos Labs
National Science Foundation (IOS 1755348)
Article History
First Online: 12 February 2025
Competing interests
: C.L.S. is a paid consultant for Bayer and Merck and receives sponsored research support from GSK. The remaining authors declare no competing interests.